bluuebunny/crossref_metadata_2025_split huggingface dataset:
A Varian DynaLog file‐based procedure for patient dose‐volume histogram‐based IMRT QA
Authors: Calvo‐Ortega Juan F. , Teke Tony , Moragues Sandra , Pozo Miquel , Casals Joan 
Published: February 2017

In the present study, we describe a method based on the analysis of the dynamic MLC log files (DynaLog) generated by the controller of a Varian linear accelerator in order to perform patient‐specific IMRT QA. The DynaLog files of a Varian Millennium MLC, recorded during an IMRT treatment, can be processed using a MATLAB‐based code in order to generate the actual fluence for each beam and so recalculate the actual patient dose distribution using the Eclipse treatment planning system. The accuracy of the DynaLog‐based dose reconstruction procedure was assessed by introducing ten intended errors to perturb the fluence of the beams of a reference plan such that ten subsequent erroneous plans were generated. In‐phantom measurements with an ionization chamber (ion chamber) and planar dose measurements using an EPID system were performed to investigate the correlation between the measured dose changes and the expected ones detected by the reconstructed plans for the ten intended erroneous cases. Moreover, the method was applied to 20 cases of clinical plans for different locations (prostate, lung, breast, and head and neck). A dose‐volume histogram (DVH) metric was used to evaluate the impact of the delivery errors in terms of dose to the patient. The ionometric measurements revealed a significant positive correlation between the variations of the dose induced in the erroneous plans with respect to the reference plan and the corresponding changes indicated by the DynaLog‐based reconstructed plans. The EPID measurements showed that the accuracy of the DynaLog‐based method to reconstruct the beam fluence was comparable with the dosimetric resolution of the portal dosimetry used in this work . The DynaLog‐based reconstruction method described in this study is a suitable tool to perform a patient‐specific IMRT QA. This method allows us to perform patient‐specific IMRT QA by evaluating the result based on the DVH metric of the planning CT image (patient DVH‐based IMRT QA).PACS number: 87.55.Qr
Evaluation of semiempirical VMAT dose reconstruction on a patient dataset based on biplanar diode array measurements
Authors: Stambaugh Cassandra , Opp Daniel , Wassrman Stuart , Zhang Geoffrey , Feygelman Vladimir 
Published: February 2017

We report the results of a preclinical evaluation of recently introduced commercial tools for 3D patient IMRT/VMAT dose reconstruction, the Delta4 Anatomy calculation algorithm. Based on the same initial measurement, volumetric dose can be reconstructed in two ways. Three‐dimensional dose on the Delta4 phantom can be obtained by renormalizing the planned dose distribution by the measurement values (D4 Interpolation). Alternatively, incident fluence can be approximated from the phantom measurement and used for volumetric dose calculation on an arbitrary (patient) dataset with a pencil beam algorithm (Delta4 PB). The primary basis for comparison was 3D dose obtained by previously validated measurement‐guided planned dose perturbation method (ACPDP), based on the ArcCHECK dosimeter with 3DVH software. For five clinical VMAT plans, D4 Interpolation agreed well with ACPDP on a homogeneous cylindrical phantom according to gamma analysis with local dose‐error normalization. The average agreement rates were (1 SD), (range 97.0%‐100%) and (89.5%‐99.2%), for the and criteria, respectively. On a similar geometric phantom, D4 PB demonstrated substantially lower agreement rates with ACPDP: (81.2%‐96.1%) and (62.1%‐81.1%), for and , respectively. The average agreement rates on the heterogeneous patients' CT datasets are lower yet: (70.4%‐90.4%) and (56.5%‐74.7%), respectively, for the same two criteria sets. For both threshold combinations, matched analysis of variance (ANOVA) multiple comparisons showed statistically significant differences in mean agreement rates for D4 Interpolation versus ACPDP on one hand, and D4 PB versus ACPDP on either cylindrical or patient dataset on the other hand. Based on the favorable D4 Interpolation results for VMAT plans, the resolution of the reconstruction method rather than hardware design is likely to be responsible for D4 PB limitations.PACS number: 87.55Qr
Importance of CBCT setup verification for optical‐guided frameless radiosurgery
Authors: Fu Lei , Perera Harold , Ying Xiao , Yu Yan 
Published: February 2017

The purpose of this study is to quantify the discrepancy between optical guidance platform (OGP) frameless localization system (Varian) and Trilogy on‐board imaging (OBI) system (Varian) for setting up phantom and stereotactic radiosurgery (SRS) patient; and to determine whether cone‐beam CT (CBCT) is necessary for OGP patient setup, and compare CBCT and orthogonal kV‐kV in term of their verification capability. Three different phantoms were used in the study: a custom‐made phantom, a Penta‐Guide phantom, and a RANDO phantom. Five patients using both OGP and CBCT setup and 14 patients using CBCT setup alone were analyzed. One patient who had big couch shifts discrepancy between OGP and CBCT was selected for further investigation. Same patient's CBCT and planning CT were fused. A RANDO phantom simulation experiment was performed using OGP setup with both CBCT and orthogonal kV‐kV verification. For all of three phantom experiments, the shifts performed by CBCT beam and orthogonal kV–kV were all within 1 mm. Among five SRS patients using OGP setup, three had 3D couch corrections more than 3 mm. The image fusion of CBCT and planning CT clearly illustrated a tilt of bite‐block in a patient's mouth. For 14 SRS patients using CBCT‐guided setup, overall 3D correction was 3.3 ± 1.5 mm. RANDO phantom experiment demonstrated how a tilted bite‐block caused isocenter shift. CBCT‐calculated shifts are the same as expected, but kV–kV results differed by 1–2 mm if the initial head position is tilted. The bite‐block tilting in patient's mouth is a major reason for the cause of positioning error for OGP frameless SRS setup. CBCT verification is necessary. CBCT provides more accurate couch corrections than orthogonal kV–kV when head was tilted. OGP is useful for detecting patient movement, but it does not necessarily imply that the isocenter has moved.PACS numbers: 87.55.km, 87.55.Qr, 87.53.Ly
An anthropomorphic spine phantom for proton beam approval in NCI‐funded trials
Authors: Cho Jongmin , Summers Paige A. , Ibbott Geoffrey S. 
Published: February 2017

As part of the approval process for the use of scattered or uniform scanning proton therapy in National Cancer Institute (NCI)‐sponsored clinical trials, the Radiological Physics Center (RPC) mandates irradiation of two RPC anthropomorphic proton phantoms (prostate and spine). The RPC evaluates these irradiations to ensure that they agree with the institutions' treatment plans within criteria of the NCI‐funded cooperative study groups. The purpose of this study was to evaluate the use of an anthropomorphic spine phantom for proton matched‐field irradiation, and to assess its use as a credentialing tool for proton therapy beams. We used an anthropomorphic spine phantom made of human vertebral bodies embedded in a tissue substitute material called Muscle Substitute/Solid Rigid Number 4 (MS/SR4) comprising three sections: a posterior section containing the posterior surface and the spinous processes, and left and right (L/R) sections containing the vertebral bodies and the transverse processes. After feasibility studies at three institutions, the phantom, containing two thermoluminescent dosimeters (TLDs) for absolute dose measurements and two sheets of radiochromic film for relative dosimetry, was shipped consecutively to eight proton therapy centers participating in the approval study. At each center, the phantom was placed in a supine or prone position (according to the institution's spine treatment protocol) and imaged with computed tomography (CT). The images then were used with the institution's treatment planning system (TPS) to generate two matched fields, and the phantom was irradiated accordingly. The irradiated phantom was shipped to the RPC for analysis, and the measured values were compared with the institution's TPS dose and profiles using criteria of ± 7% for dose agreement and 5 mm for profile distance to agreement. All proton centers passed the dose criterion with a mean agreement of 3% (maximum observed agreement, 7%). One center failed the profile distance‐to‐agreement criterion on its initial irradiation, but its second irradiation passed the criterion. Another center failed the profile distance‐to‐agreement criterion, but no repeat irradiation was performed. Thus, seven of the eight institutions passed the film profile distance‐to‐agreement criterion with a mean agreement of 1.2 mm (maximum observed agreement 5 mm). We conclude that an anthropomorphic spine phantom using TLD and radiochromic film adequately verified dose delivery and field placement for matched‐field treatments.PACS number: 87.55.‐x, 87.55.N‐
Four‐and‐one‐half years' experience in monitoring of reproducibility of an MR spectroscopy system — application of in vitro results to interpretation of in vivo data
Authors: Skorupa Agnieszka , Wicher Magdalena , Banasik Tomasz , Jamroz Ewa , Paprocka Justyna , Kiettyka Aleksandra , Sokót Maria , Konopka Marek 
Published: February 2017

The primary purpose of this work was to assess long‐term in vitro reproducibility of metabolite levels measured using 1H MRS (proton magnetic resonance spectroscopy). The secondary purpose was to use the in vitro results for interpretation of ‘H MRS in vivo spectra acquired from patients diagnosed with Canavan disease. 1H MRS measurements were performed in the period from April 2006 to September 2010. 118 short and 116 long echo spectra were acquired from a stable phantom during this period. Change‐point analysis of the in vitro N‐acetylaspartate levels was exploited in the computation of fT factor (ratio of the actual to the reference N‐acetylaspartate level normalized by the reciprocity principle). This coefficient was utilized in the interpretation of in vivo spectra analyzed using absolute reference technique. The monitored time period was divided into six time intervals based on short echo in vitro data (seven time intervals based on long echo in vitro data) characterized by fT coefficient ranging from 0.97 to 1.09 (based on short echo data) and from 1.0 to 1.11 (based on long echo data). Application of this coefficient to interpretation of in vivo spectra confirmed increased N‐acetylaspartate level in Canavan disease. Long‐term monitoring of an MRS system reproducibility, allowing for absolute referencing of metabolite levels, facilitates interpretation of metabolic changes in white matter disorders.PACS numbers: 87.19.lf, 87.61.Tg, 87.64.K‐, 87.64.kj
In‐house development of a neonatal chest simulation phantom
Authors: Groenewald Annemari , Groenewald Willem A. 
Published: February 2017

The aim of the study was to design and construct an anatomical and radiological phantom of a neonatal chest for investigating image quality and patient entrance surface dose (ESD). The density, elemental composition, scatter, attenuation, and absorption characteristics of different possible substitute materials were compared to that of neonatal tissues for radiological equivalence. Availability and cost of possible substitute materials were also considered. The most optimal substitute materials were selected to represent neonatal muscle, bone, healthy or aerated and sick or collapsed lung. For anatomical equivalence, a computed tomography (CT) scan was performed on a neonatal cadaver. Dimensions of different organs and structures were measured with software measuring tools at different window and level settings. Simplifying assumptions, due to machining limitations, were made. The results were used to create scaled drawings, which were used to machine the structures of the phantom. The phantom was assembled in a layer‐by‐layer manner and was validated with region of interest (ROI) analyses. The neonatal chest simulation phantom was an acceptable simulation of a real neonatal chest based on ROI validation, with an overall deviation of 32.5%. The phantom was successfully used in our diagnostic radiology division for ESD and image quality investigations for chest anterior‐posterior (AP) radiographs.PACS numbers: 87.57.C‐; 87.59.B‐; 41.50.+h
Monte Carlo simulation and film dosimetry for electron therapy in vicinity of a titanium mesh
Authors: Jabbari Keyvan , Rostampour Masoumeh , Roayaei Mahnaz 
Published: February 2017

Titanium (Ti) mesh plates are used as a bone replacement in brain tumor surgeries. In the case of radiotherapy, these plates might interfere with the beam path. The purpose of this study is to evaluate the effect of titanium mesh on the dose distribution of electron fields. Simulations were performed using Monte Carlo BEAMnrc and DOSXYZnrc codes for 6 and 10 MeV electron beams. In Monte Carlo simulation, the shape of the titanium mesh was simulated. The simulated titanium mesh was considered as the one which is used in head and neck surgery with a thickness of 0.055 cm. First, by simulation, the percentage depth dose was obtained while the titanium mesh was present, and these values were then compared with the depth dose of homogeneous phantom with no titanium mesh. In the experimental measurements, the values of depth dose with titanium mesh and without titanium mesh in various depths were measured. The experiments were performed using a RW3 phantom with GAFCHROMIC EBT2 film. The results of experimental measurements were compared with values of depth dose obtained by simulation. In Monte Carlo simulation, as well as experimental measurements, for the voxels immediately beyond the titanium mesh, the change of the dose were evaluated. For this purpose the ratio of the dose for the case with titanium to the case without titanium was calculated as a function of titanium depth. For the voxels before the titanium mesh there was always an increase of the dose up to 13% with respect to the same voxel with no titanium mesh. This is because of the increased back scattering effect of the titanium mesh. The results also showed that for the voxel right beyond the titanium mesh, there is an increased or decreased dose to soft tissues, depending on the depth of the titanium mesh. For the regions before the depth of maximum dose, there is an increase of the dose up to 10% compared to the dose of the same depth in homogeneous phantom. Beyond the depth of maximum dose, there was a 16% decrease in dose. For both 6 and 10 MeV, before the titanium mesh, there was always an increase in dose. If titanium mesh is placed in buildup region, it causes an increase of the dose and could lead to overdose of the adjacent tissue, whereas if titanium mesh is placed beyond the buildup region, it would lead to a decrease in dose compared to the homogenous tissue.PACS number: 87.53.Bn
A dosimetry technique for measuring kilovoltage cone‐beam CT dose on a linear accelerator using radiotherapy equipment
Authors: Scandurra Daniel , Lawford Catherine E. 
Published: February 2017

This work develops a technique for kilovoltage cone‐beam CT (CBCT) dosimetry that incorporates both point dose and integral dose in the form of dose length product, and uses readily available radiotherapy equipment. The dose from imaging protocols for a range of imaging parameters and treatment sites was evaluated. Conventional CT dosimetry using 100 mm long pencil chambers has been shown to be inadequate for the large fields in CBCT and has been replaced in this work by a combination of point dose and integral dose. Absolute dose measurements were made with a small volume ion chamber at the central slice of a radiotherapy phantom. Beam profiles were measured using a linear diode array large enough to capture the entire imaging field. These profiles were normalized to absolute dose to form dose line integrals, which were then weighted with radial depth to form the DLPCBCT. This metric is analogous to the standard dose length product (DLP), but derived differently to suit the unique properties of CBCT. Imaging protocols for head and neck, chest, and prostate sites delivered absolute doses of 0.9, 2.2, and 2.9 cGy to the center of the phantom, and of 28.2, 665.1, and 565.3 mGy.cm, respectively. Results are displayed as dose per 100 mAs and as a function of key imaging parameters such as kVp, mAs, and collimator selection in a summary table. was found to correlate closely with the dimension of the imaging region and provided a good indication of integral dose. It is important to assess integral dose when determining radiation doses to patients using CBCT. By incorporating measured beam profiles and DLP, this technique provides a CBCT dosimetry in radiotherapy phantoms and allows the prediction of imaging dose for new CBCT protocols.PACS number: 87.57.uq
Effects of spatial resolution and noise on gamma analysis for IMRT QA
Authors: Huang Jessie Y. , Pulliam Kiley B. , McKenzie Elizabeth M. , Followill David S. , Kry Stephen F. 
Published: February 2017

We investigated the sensitivity of the gamma index to two factors: the spatial resolution and the noise level in the measured dose distribution. We also examined how the choice of reference distribution and analysis software affect the sensitivity of gamma analysis to these two factors for quality assurance (QA) of intensity‐modulated radiation therapy (IMRT) treatment plans. For ten clinical IMRT plans, the dose delivered to a transverse dose plane was measured with EDR2 radiographic film. To evaluate the effects of spatial resolution, each irradiated film was digitized using three different resolutions (71, 142, and 285 dpi). To evaluate the effects of image noise, 1% and 2% local Gaussian noise was added to the film images. Gamma analysis was performed using 2%/2 mm and 3%/3 mm acceptance criteria and two commercial software packages, OmniPro I'mRT and DoseLab Pro. Dose comparisons were performed with the treatment planning system (TPS)‐calculated dose as the reference, and then repeated with the film as the reference to evaluate how the choice of reference distribution affects the results of dose comparisons. When the TPS‐calculated dose was designated as the reference distribution, the percentage of pixels with passing gamma values increased with both increasing resolution and noise. For 3%/3 mm acceptance criteria, increasing the film image resolution by a factor of two and by a factor of four caused a median increase of 0.9% and 2.6%, respectively, in the percentage of pixels passing. Increasing the noise level in the film image resulted in a median increase in percentage of pixels passing of 5.5% for 1% added local Gaussian noise and 5.8% for 2% added noise. In contrast, when the film was designated as the reference distribution, the percentage of pixels passing decreased with increased film noise, while increased resolution had no significant effect on passing rates. Furthermore, the sensitivity of gamma analysis to noise and resolution differed between OmniPro I'mRT and DoseLab Pro, with DoseLab Pro being less sensitive to the effects of noise and resolution. Noise and high scanning resolution can artificially increase the percentage of pixels with passing gamma values in IMRT QA. Thus, these factors, if not properly taken into account, can potentially affect the results of IMRT QA by causing a plan that should be classified as failing to be falsely classified as passing. In designing IMRT QA protocols, it is important to be aware that gamma analysis is sensitive to these parameters.PACS number: 87.55.Qr, 87.55.km, 87.56.Fc
Bremsstrahlung dose of 165Dy in radiosynovectomy
Authors: Manjunatha H.C. 
Published: February 2017

There has been an increased interest in 165Dy radiossynovectomy, which emits relatively high‐energy (> 1 MeV) beta rays. The production of in vivo bremsstrachlung radiation hazards warrants evaluation. The bremsstrahlung component of the decay scheme of 165Dy has been traditionally ignored in internal dosimetry calculations. We have estimated the bremsstrahlung dose of 165Dy distributed in muscle and bone to body by various internal organs (adrenals, brain, breasts, gallbladder wall, LLI wall, small intestine, stomach, ULI wall, heart wall, kidneys, liver, lungs, muscle, ovaries, pancreas, red marrow, bone surfaces, skin, spleen, testes, thymus, thyroid, urine bladder wall, uterus, fetus, placenta, and total body) during radiosynovictomy. In the present study, muscle and bone are considered to be source organs. These estimated values show that the bremsstrahlung radiation absorbed dose contribution from an organ to itself is very small compared to that originating from the beta source. However, contribution to other organs is not always negligible, especially when large amounts of 165Dy may be involved, such as in therapy applications. Hence the component of the total dose due to bremsstrahlung dose should be considered in radiosynovictomy or other therapy applications.PACS numbers: 34.80.‐i, 78.70.‐g, 33.20.Rm, 34.50.Bw
Two‐dimensional in vivo dose verification using portal imaging and correlation ratios
Authors: Peca Stefano , Brown Derek W. 
Published: February 2017

The electronic portal imaging device (EPID) has the potential to be used for in vivo dosimetry during radiation therapy as an additional dose delivery check. In this study we have extended a method developed by A. Piermattei and colleagues in 2006 that made use of EPID transit images (acquired during treatment) to calculate dose in the isocenter point. The extension allows calculation of two‐dimensional dose maps of the entire radiation field at the depth of isocenter. We quantified the variability of the ratio of EPID signal to dose in the isocenter plane in Solid Water phantoms of various thicknesses and with various field sizes, and designed a field edge dose calculation correction. To validate the method, we designed three realistic conventional radiation therapy treatment plans on a thorax and head anthropomorphic phantom (whole brain, brain primary, lung tumor). Using CT data, EPID transit images, EPID signal‐to‐dose correlation, and our edge correction, we calculated dose in the isocenter plane and compared it with the treatment planning system's prediction. Gamma evaluation (3%, 3 mm) showed good agreement (Pγ<1 ≥ 96.5%) for all fields of the whole brain and brain primary plans. In the presence of lung, however, our algorithm overestimated dose by 7%–9%. This 2D EPID‐based in vivo dosimetry method can be used for posttreatment dose verification, thereby improving the safety and quality of patient treatments. With future work, it may be extended to measure dose in real time and to prevent harmful delivery errors.PACS numbers: 87.55.km, 87.55.Qr, 87.55.T‐